Diana Do, MD, a professor of ophthalmology and vice chair of Clinical Affairs at Stanford University's Byers Eye Institute, presented research on aflibercept 8 mg in treating neovascular age-related ...

Stoke Therapeutics announced 2-year data from the FALCON study, a prospective natural history study in people with autosomal ...

Phase 2 STARLIGHT study participants, particularly those with the macular phenotype, experienced meaningful gains in visual ...

Aurion Biotech has released positive 12-month results from its phase 1/2 CLARA trial evaluating the safety, efficacy, and ...

Glaukos announced that the FDA has approved the new drug application for its topical drug therapy (Epioxa HD/Epioxa) for keratoconus. 1,2 This approval makes it the first FDA-approved corneal ...

Bedrood describes improved visualization of the ciliary body, efficient setup, and favorable postoperative outcomes.

Innovations in selective laser trabeculoplasty and laser cyclophotocoagulation focus on procedural efficiency, patient ...

Philip J. Ferrone, MD, is partner with Vitreoretinal Consultants of New York and professor of ophthalmology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell.